ClinicalTrials.Veeva

Menu

HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

T

Tianjin Nankai Hospital

Status

Enrolling

Conditions

Sepsis

Treatments

Other: nothing

Study type

Observational

Funder types

Other

Identifiers

NCT06045780
NKYY_YXKT_IRB_2023_049_01

Details and patient eligibility

About

This study was an ambispective observational cohort study that included sepsis patients hospitalized in the Intensive care unit (ICU) of the Nankai Hospital. All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.

Full description

All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Males or females over the age of 18;
  2. Sepsis was diagnosed within 48h which meets SPESIS 3 criteria;
  3. Capable of understanding the purpose and risk of the study;
  4. Patients or proxy must give written informed consent before any assessment is performed.

Exclusion criteria

  1. Pregnancy, lactation or perinatal period;
  2. Breast carcinoma;
  3. HIV seropositive or Syphilis seropositive;
  4. Any clinical-relevant condition that might affect study participation and/or study results;
  5. Participation in any other intervention trial;
  6. Unwillingness or inability to following the study protocol in the investigators opinion.

Trial design

150 participants in 2 patient groups

Sepsis
Description:
disease
Treatment:
Other: nothing
Healthy controls
Description:
healthy
Treatment:
Other: nothing

Trial contacts and locations

1

Loading...

Central trial contact

Jianbo Yu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems